首页> 外文OA文献 >Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children▿
【2h】

Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children▿

机译:小儿化脓性链球菌引起的扁桃体咽炎的药效分析和临床试验,每天一次7天服用阿莫西林与青霉素V钾10天每天服用4次青霉素V相比

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An a priori pharmacokinetic/pharmacodynamic (PK/PD) target of 40% daily time above the MIC (T >MIC; based on the MIC90 of 0.06 μg/ml for Streptococcus pyogenes reported in the literature) was shown to be achievable in a phase 1 study of 23 children with a once-daily (QD) modified-release, multiparticulate formulation of amoxicillin (amoxicillin sprinkle). The daily T >MIC achieved with the QD amoxicillin sprinkle formulation was comparable to that achieved with a four-times-daily (QID) penicillin VK suspension. An investigator-blinded, randomized, parallel-group, multicenter study involving 579 children 6 months to 12 years old with acute streptococcal tonsillopharyngitis was then undertaken. Children were randomly assigned 1:1 to receive either the amoxicillin sprinkle (475 mg for ages 6 months to 4 years, 775 mg for ages 5 to 12 years) QD for 7 days or 10 mg/kg of body weight of penicillin VK QID for 10 days (up to the maximum dose of 250 mg QID). Unexpectedly, the rates of bacteriological eradication at the test of cure were 65.3% (132/202) for the amoxicillin sprinkle and 68.0% (132/194) for penicillin VK (95% confidence interval, −12.0% to 6.6%). Thus, neither antibiotic regimen met the minimum criterion of ≥85% eradication ordinarily required by the U.S. FDA for first-line treatment of tonsillopharyngitis due to S. pyogenes. The results of subgroup analyses across demographic characteristics and current infection characteristics and by age/weight categories were consistent with the primary-efficacy result. The clinical cure rates for amoxicillin sprinkle and penicillin VK were 86.1% (216/251) and 91.9% (204/222), respectively (95% confidence interval, −11.6% to −0.4%). The results of a post hoc PD analysis suggested that a requirement for 60% daily T >MIC90 more accurately predicted the observed high failure rates for bacteriologic eradication with the amoxicillin sprinkle and penicillin VK suspension studied. Based on the association between longer treatment courses and maximal bacterial eradication rates reported in the literature, an alternative composite PK/PD target taking into consideration the duration of therapy, or total T >MIC, was considered and provides an alternative explanation for the observed failure rate of amoxicillin sprinkle.
机译:已证明在某一阶段可实现先于MIC高于每日40%的先期药代动力学/药效学(PK / PD)目标(T> MIC;基于化脓性链球菌的MIC90为0.06μg/ ml)一项针对23名儿童的阿莫西林每日一次(QD)改良释放,多颗粒配方(阿莫西林洒)的研究。用QD阿莫西林洒剂实现的每日T> MIC与每天四次(QID)青霉素VK悬浮液所实现的每日T> MIC相当。然后进行了一项研究者盲,随机,平行分组,多中心研究,研究对象为579名6个月至12岁的急性链球菌性扁桃体咽炎的儿童。将儿童随机分配为1:1,以接受阿莫西林散剂(6个月至4岁年龄段为475 mg,5至12岁年龄段为775 mg)QD 7天或青霉素VK QID体重为10 mg / kg体重10天(最高250 mg QID剂量)。出乎意料的是,阿莫西林散剂在治愈测试中的细菌清除率为65.3%(132/202),青霉素VK为68.0%(132/194)(95%置信区间为-12.0%至6.6%)。因此,两种抗生素方案均未达到美国FDA对化脓性链球菌引起的扁桃体咽喉炎的一线治疗通常所要求的根除≥85%的最低标准。跨人群特征和当前感染特征以及按年龄/体重类别进行的亚组分析结果与主要疗效结果一致。阿莫西林散和青霉素VK的临床治愈率分别为86.1%(216/251)和91.9%(204/222)(95%置信区间为-11.6%至-0.4%)。事后PD分析的结果表明,每天60%的T> MIC90的需求可以更准确地预测所观察到的阿莫西林洒水和青霉素VK悬浮液对细菌根除的高失败率。基于文献报道的更长疗程和最大细菌根除率之间的关联,考虑了治疗持续时间或总T> MIC的替代性复合PK / PD靶点,为观察到的失败提供了替代性解释。阿莫西林的喷洒率。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号